Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HIV
HIV
Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study
Yahoo/Reuters
Thu, 02/26/15 - 04:46 pm
Bristol-Myers Squibb
hepatitis C
HIV
daclatasvir
Merck gives free license allowing cheap versions of its HIV drug for children in poor nations
Yahoo/AP
Tue, 02/24/15 - 09:18 am
Merck
HIV
developing countries
New Potential HIV Vaccine Drug 'Absolutely 100% Effective' In Monkeys
Yahoo/Benzinga
Fri, 02/20/15 - 09:19 am
HIV
vaccines
Scripps Research Institute
eCD4-IG
FDA approves Bristol-Myers' HIV drug
Yahoo/Reuters
Thu, 01/29/15 - 07:20 pm
FDA
Bristol-Myers Squibb
HIV
Reyataz
AbbVie Strikes Hepatitis C Discount Deal With AIDS Drug Programs
Bloomberg
Mon, 01/19/15 - 12:06 pm
AbbVie
hepatitis C
AIDS
HIV
Viekira Pak
Exclusive - More unit IPOs an option for evolving GlaxoSmithKline
Yahoo/Reuters
Fri, 01/16/15 - 10:09 am
IPOs
GSK
Novartis
HIV
Gilead Sciences, Inc. Can't Do It Alone
Motley Fool
Mon, 12/29/14 - 09:10 pm
Gilead Sciences
HIV
JNJ
Gilead and Janssen expand partnership in HIV
Seeking Alpha
Mon, 12/29/14 - 10:55 am
Gilead Sciences
Janssen
HIV
tenofovir
rilpivirine
emtricitabine
Mylan to Manufacture, Distribute Gilead Sciences HIV Drug
Marketwatch
Mon, 12/1/14 - 09:58 am
Mylan Labs
HIV
Gilead Sciences
tenofovir
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Fierce Biotech
Wed, 10/22/14 - 08:32 am
GSK
ViiV Healthcare
IPOs
HIV
Pfizer
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance
Yahoo/Zacks
Sat, 09/27/14 - 09:31 am
Gilead Sciences
Tybost
Vitekta
HIV
Gilead's New HIV Drug Key To Long-Term Strategy
Investors.com
Wed, 09/24/14 - 06:43 pm
Gilead Sciences
HIV
tenofovir
Gilead Sciences: A Preview of Important HIV Drug Study Results
TheStreet.com
Mon, 09/22/14 - 02:48 pm
Gilead Sciences
HIV
tenofovir
ViiV’s Triumeq to end Gilead’s monopoly in HIV
Pharmaphorum
Wed, 09/10/14 - 11:33 am
ViiV Healthcare
Gilead Sciences
HIV
Triumeq
Glaxo, Pfizer’s ViiV Wins Approval for HIV Combo Drug
Bloomberg
Sat, 08/23/14 - 09:50 am
Glaxo
Pfizer
ViiV
HIV
Gilead bags a portfolio of HIV-neutralizing antibodies
Fierce Biotech
Wed, 07/30/14 - 06:37 pm
Gilead Sciences
antibodies
HIV
Celgene drug can drive HIV out of hiding -study
Yahoo/Reuters
Tue, 07/22/14 - 08:50 am
HIV
Celgene
romidepsin
AIDS
Gilead Drug Combination Cures Hepatitis C in HIV Patients
Yahoo/Bloomberg
Mon, 07/21/14 - 09:13 am
Gilead Sciences
HIV
hepatitis C
Sovaldi
Ribavirin
1 Hidden Blockbuster Lurking in Merck's Pipeline?
Motley Fool
Mon, 07/14/14 - 07:01 pm
Merck
Doravirine
MK-1439
HIV
Isentress
1 Drug More Important to Gilead Than Sovaldi
Motley Fool
Sat, 07/12/14 - 10:37 am
Truvada
Gilead Sciences
HIV
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »